Since June 2009, genetic analysis and experiments have been carried out at RIKEN GENESIS in compliance with our RG-GLP, which is based on the GLP (Good Laboratory Practice) ordinance for pharmaceuticals.

RG-GLP Framework：

RIKEN GENESIS have accreditation for its genetic analysis service from the College of American Pathologists (CAP) since May 2010.

RIKEN GENESIS was the first CAP accredited facility in Japan as an independent genetic analysis laboratory. CAP accreditation, which is granted through examination and inspection of clinical test laboratories, confers recognition of the technical standards of the systems.

CAP accreditation is testament to the world-class quality assurance and reliability of technology. Results of genetic analysis carried out by RIKEN GENESIS will be accepted by the US Food and Drug Administration (FDA).